News Roundup: June 19 to June 23
Sandoz Launches Action Plan to Increase Global Biosimilar Access
The Act4Biosimilars Action Plan aims to highlight key challenges preventing patient access to biosimilars and outline steps to help overcome them.
Insurance Coverage is Lagging in a Golden Age of Obesity Treatment
Antiobesity medications are considered to be 'vanity drugs' by many private insurers, and the refusal to cover obesity treatment is counterproductive because of obesity's many health consequences.
First Gene Therapy to Treat Pediatric Duchenne Muscular Dystrophy Approved by FDA
The accelerated approval of delandistrogene moxeparvovec-rokl is “based on expression of Elevidys micro-dystrophin observed in patients treated with ELEVIDYS,” according to Sarepta Therapeutics.
What’s New in Next-Generation Vaccines for Respiratory Viruses?
A recent review evaluated possible approaches for new vaccines targeting respiratory viruses.
The Effectiveness of Biologics in Preventing Penetrating Complications in Patients With CD
A study presented at Digestive Disease Week 2023 compared the effectiveness of different approaches to prevent complications in individuals with the common disease.
Challenges for Pharmacies in 2025: What to Expect and How to Prepare
January 8th 2025Pharmacy professionals are used to overcoming obstacles in this competitive, dynamic field. But the coming year will bring challenges affecting patient care, the industry workforce and their business. Pharmacies must be ready to do more than weather the storm; they need deliberate strategy and sophisticated tools to thrive amidst these obstacles. This white paper will discuss the issues and solutions that should be at the top of every pharmacy professional’s mind as they start the new year.
